Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
ClinicalTrials.gov
Exhaled Breath Condensate pH in Mechanically Ventilated Patients
OBSERVATIONAL
Inicio: 1 de ago de 2007
ID: NCT01393431
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of SYN115 as Adjunctive Therapy in Levodopa-treated Parkinson's Subjects With End of Dose Wearing Off
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01283594
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01684345
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia
INTERVENTIONAL
Inicio: 20 de jul de 2022
ID: NCT05256654
Completado
Fase 3
ClinicalTrials.gov
Extension Study to the Multicenter, Open-label, Randomized, Controlled Study CRAD001H2304 to Evaluate the Long-term Efficacy and Safety of Concentration-controlled Everolimus in Liver Transplant Recipient
INTERVENTIONAL
Inicio: 31 de mar de 2010
ID: NCT01150097
Completado
Fase 2
ClinicalTrials.gov
A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in DMD
INTERVENTIONAL
Inicio: 1 de sept de 2005
ID: NCT00243789
Completado
Fase 3
ClinicalTrials.gov
Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy.
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00335452
Completado
Fase 3
ClinicalTrials.gov
RECITE: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy- Induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer
INTERVENTIONAL
Inicio: 30 de sept de 2019
ID: NCT03362177
Completado
Fase 1
ClinicalTrials.gov
A Phase Ib, Open-Label Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
INTERVENTIONAL
Inicio: 17 de ago de 2022
ID: NCT05487235
Completado
Fase 3
ClinicalTrials.gov
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PHASE III STUDY TO ASSESS THE EFFICACY,SAFETY AND TOLERABILITY OF ALEGLITAZAR ADDED TO A SU OR ADDED TO A SU IN COMBINATION WITH MET IN PATIENTS WITH T2D INADEQUATELY CONTROLLED WITH SU MONOTHERAPY OR WITH SU + METFORMIN COMBINATION THERAPY
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01691989
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 Versus Placebo Over 104 Weeks in the Prevention of Recurrence of Diverticulitis.
INTERVENTIONAL
Inicio: 28 de nov de 2007
ID: NCT00545740
Completado
Fase 3
ClinicalTrials.gov
A Randomized 8-week Double-blind, Parallel-group, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of LCZ696 200 mg in Comparison With Olmesartan 20 mg in Essential Hypertensive Patients Not Responsive to Olmesartan
INTERVENTIONAL
Inicio: 1 de sept de 2013
ID: NCT01876368
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia
INTERVENTIONAL
Inicio: 31 de ago de 2022
ID: NCT05552326
Completado
ClinicalTrials.gov
Weighting of Balance Deficiencies Performed by Physical Therapist in Argentina in Subjects With Risk of Falling
OBSERVATIONAL
Inicio: 1 de dic de 2022
ID: NCT05285150
Completado
ClinicalTrials.gov
A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay
INTERVENTIONAL
Inicio: 1 de oct de 2011
ID: NCT01852617
Completado
Fase 3
ClinicalTrials.gov
Open-label, Interventional, Cohort Study to Evaluate Long-term Safety of Dupilumab in Patients With Moderate to Severe Asthma Who Completed the TRAVERSE-LTS12551 Clinical Trial
INTERVENTIONAL
Inicio: 30 de ago de 2018
ID: NCT03620747
Terminado
Fase 3
ClinicalTrials.gov
Phase 3 Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (Pf-04950615) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects.
INTERVENTIONAL
Inicio: 29 de oct de 2013
ID: NCT01975376
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label, Parallel-Group, Randomized, Flexible Dose Study To Evaluate the Safety and Tolerability of Switching From Existing Atypical Antipsychotics to Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00347425
Completado
Fase 4
ClinicalTrials.gov
Efficacy and Safety of Difluprednate Ophthalmic Emulsion vs. a Fixed-Combination of Prednisolone Acetate - Phenylephrine Ophthalmic Suspension on Post-operative Inflammation Following Cataract Surgery.
INTERVENTIONAL
Inicio: 24 de mar de 2019
ID: NCT04631315
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.
INTERVENTIONAL
Inicio: 22 de dic de 2022
ID: NCT05531149
Anterior
1
...
406
407
408
...
434
Siguiente
Filtros